Are you Dr. Shelburne?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 81 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Samuel Shelburne, MD is an infectious disease specialist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
Baylor College of MedicineFellowship, Infectious Disease, 2002 - 2005- Baylor College of MedicineResidency, Internal Medicine, 1998 - 2002
University of Texas Medical Branch School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsBacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease.Eiko Hayase, Tomo Hayase, Akash Mukherjee, Stuart C Stinson, Mohamed A Jamal
Cell Host & Microbe. 2024-09-11 - Persistence of Daptomycin-Resistant and Vancomycin-Resistant Enterococci in Hospitalized Patients with Underlying Malignancies: A 7-Year Follow-Up Study.Lynn El Haddad, Georgios Angelidakis, Yuting Zhai, Layale Yaghi, Cesar A Arias
Microorganisms. 2024-08-14 - 1 citationsCefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes inof clinical origin.Stephanie L Egge, Samie A Rizvi, Shelby R Simar, Manuel Alcalde, Jose R W Martinez
Antimicrobial Agents and Chemotherapy. 2024-08-07
Press Mentions
Editorial BoardJune 24th, 2020
